President Donald Trump suggested Tuesday his administration intends to impose a 200% tariff rate on pharmaceutical imports ...

CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Donald Trump said Tuesday he’s imposing a new 50% tariff on all copper. However, it’s unclear when the new tariff ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

While the bilateral trade negotiations are in the final stages of discussion between India and the US, the tariffs announced ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Trump suggested that those levies would not go into effect immediately, saying he will “give people about a year, year and a half” ...

President Trump announced his intent to impose tariffs on imported pharmaceuticals and semiconductors, which may reach 200%.

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...